US 2020/0348300 A1 · MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS IMMUNODIAGNOSTIC ANTIGENS, METHODS, AND KITS COMPRISING SAME

Mycobacterium avium subspecies paratuberculosis immunodiagnostic antigens, methods, and kits comprising same

AssigneesThe Penn State Research Foundation, IMMPORT THERAPEUTICS, INC., d/b/a ANTIGEN DISCOVERY, INC., Cornell University, The United States of America as represented by the Secretary of Agriculture

InventorsVivek Kapur, Lingling Li, Joseph J. Campo, Yrjo T. Grohn, Bettina Wagner, John P. Bannantine, Judith R. Stabel

Life of this patent

Estimating the term…

Abstract

The present invention provides novel Mycobacterium avium subspecies paratuberculsis (MAP) derived antigens which may be used to diagnose and thereafter effectively treat animals that have been infected with MAP, Further provided are methods of determining whether an animal is infected with MAP, and methods of diagnosing and treating Johne's disease. The invention also relates to a kit for the implementation of the methods.

Claims37

Dependent claims

A method of determining whether an animal is infected with Mycobacterium avium subspecies paratuberculosis (MAP), the method comprising:

(a) obtaining a sample from the animal;
and
(b) detecting the presence or absence of the binding of a biomarker in the sample with one or more MAP derived antigens.

Dependencies are inferred from the claim text.